Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

PURPOSE: Patients with centrally located early-stage non–small-cell lung cancer (NSCLC) are at a higher risk of toxicity from high-dose ablative radiotherapy. NRG Oncology/RTOG 0813 was a phase I/II study designed to determine the maximum tolerated dose (MTD), efficacy, and toxicity of stereotactic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Bezjak, Andrea, Paulus, Rebecca, Gaspar, Laurie E., Timmerman, Robert D., Straube, William L., Ryan, William F., Garces, Yolanda I., Pu, Anthony T., Singh, Anurag K., Videtic, Gregory M., McGarry, Ronald C., Iyengar, Puneeth, Pantarotto, Jason R., Urbanic, James J., Sun, Alexander Y., Daly, Megan E., Grills, Inga S., Sperduto, Paul, Normolle, Daniel P., Bradley, Jeffrey D., Choy, Hak
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524984/
https://ncbi.nlm.nih.gov/pubmed/30943123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00622
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados